Sort
17,828 grants matching “crispr”
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
$573,842James Christopher Costello · University Of Colorado Denver · R01 · FY2025 · CA
Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence
$573,738Sam Anthony Myers · La Jolla Institute For Immunology · R01 · FY2024 · CA
The Investigation of disease causing genes in C. elegans
$573,443Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Center for Structural Biology of HIV RNA
$573,330Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2025 · AI
Center for Structural Biology of HIV RNA
$573,330Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2025 · AI
Developing Regeneration Resources for a Model Amphibian
$573,257Stephen Randal Voss · University Of Kentucky · R24 · FY2017 · OD
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.
$573,246Stavros Lomvardas · Columbia University Health Sciences · U01 · FY2018 · DA
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.
$573,246Stavros Lomvardas · Columbia University Health Sciences · U01 · FY2017 · DA
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.
$573,246Stavros Lomvardas · Columbia University Health Sciences · U01 · FY2019 · DA
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.
$573,246Stavros Lomvardas · Columbia University Health Sciences · U01 · FY2016 · DA
Deciphering nuclear bodies and compartments that govern singular olfactory receptor expression.
$573,245Stavros Lomvardas · Columbia University Health Sciences · U01 · FY2015 · DA
Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity
$573,207Derya Unutmaz · Jackson Laboratory · U19 · FY2023 · AI
Identification and characterization of chemical probes of TRIO GEF1 activity
$573,147Anthony J Koleske · Yale University · R01 · FY2024 · MH
Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis
$573,075Katja Gabriele Weinacht · Stanford University · R01 · FY2024 · HL
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$573,041Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Vascular autophagy as a mediator of vascular aging and homeostasis
$572,989Toren Finkel · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · HL
Prostate Cancer Risk Enhancers
$572,877Gerhard A Coetzee · University Of Southern California · R01 · FY2015 · CA
Mechanisms of DUX4 mediated FSHD pathology
$572,861Peter L Jones · University Of Nevada Reno · R01 · FY2024 · AR
Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice
$572,736Camron D Bryant · Boston University Medical Campus · R01 · FY2016 · DA
Molecular mechanisms underlying the preservation of neural stem cell quiescence during aging
$572,715Ashley E Webb · Buck Institute For Research On Aging · R01 · FY2025 · AG
Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity
$572,263Derya Unutmaz · Jackson Laboratory · U19 · FY2021 · AI
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV
$571,893Peter Jesse Gaskill · Drexel University · R61 · FY2024 · DA
Readily Available Biological Conduits to Treat Single Ventricle Defects
$571,889Yibing Qyang · Yale University · R01 · FY2024 · HL
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$571,883David R Liu · Harvard University · R35 · FY2016 · GM
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$571,785David Andrew Largaespada · University Of Minnesota · R01 · FY2023 · NS